Emerging Pathogen: Candida kefyr (Kluvyeromyces marxianus)

被引:3
|
作者
Cuhadar, Tugba [1 ]
Kalkanci, Ayse [1 ]
机构
[1] Gazi Univ, Fac Med, Dept Med Microbiol, TR-06500 Ankara, Turkey
来源
MIKROBIYOLOJI BULTENI | 2017年 / 51卷 / 04期
关键词
Candida kefyr; incidence; antifungal susceptibility; virulence; sequencing; EPIDEMIOLOGIC CUTOFF VALUES; ANTIFUNGAL SUSCEPTIBILITY; RISK-FACTORS; RESISTANCE; IDENTIFICATION;
D O I
10.5578/mb.61813
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the central microbiology laboratory of Gazi University Hospital Candida kefyr was isolated from different clinical samples as 5.3% in 2016 and in 2017 this rate increased to 9.3% which was nearly twofold and this has drawn our attention. The aim of this study was to evaluate the special characteristics, antifungal susceptibility and virulence properties of C. keyfr species. Germ tube, corn meal-tween 80 agar morphology and carbohydrate assimilation profiles on ID32C yeast identification system were used for the diagnosis of Candida species. In this study, DNA sequencing was performed using ITS1 and ITS4 primers amplifying fungal gene between 5.8S and 18S regions of rRNA. Antifungal susceptibility was performed using M27A microdilution method recommended by Clinical and Laboratory Standards Institute (CLSI). Minimum inhibitory concentration (MIC) values for amphotericin B, fluconazole, voriconazole and itraconazole were determined. MIC distribution, MIC50 and MIC90 values and geometric mean (GM) were detected. The existence of virulence factors caseinase, secreted aspartyl proteinase, esterase and phospholipase were investigated in vitro. A total of 865 Candida species were isolated from different clinical samples in the central microbiology laboratory of Gazi University Hospital in 2016. Among them, 46 (5.3%) were C. kefyr. In the first four months of 2017, 30 (9.3%) C. kefyr were identified among 320 Candida isolates. Ten isolates which have shown atypical morphology on corn meal agar were selected. Among these 10 isolates, nine of them were identified as C. kefyr by using ID32C system and DNA sequencing method. Amphotericin B MIC value was 2 mu g/ml for one isolate, and fluconazole MIC value was 8 mu g/ml for another isolate among 46 isolates. Among the 30 isolates of the year 2017, one of them presented MIC value for fluconazole as 8 mu g/ml. No marked antifungal resistance was detected in our isolate group. Caseinase was positive in one C. kefyr isolate, and phospholipase were positive in eight of nine isolates. As a result, the reason of increase in the incidence of this Candida species, which does not show significant resistance and presents mostly phospholipase activity as a virulence factor, should be investigated in more detail.
引用
收藏
页码:387 / 395
页数:9
相关论文
共 50 条
  • [1] Emerging pathogen: Candida kefyr (Kluvyeromyces marxianus) in pediatric hematopoietic stem cell transplant recipients
    Yilmaz, Ebru
    Erdogmus, Arda
    Ucan, Gulsah
    Atalay, Altay
    Ozcan, Alper
    Patiroglu, Turkan
    Karakukcu, Musa
    Unal, Ekrem
    BONE MARROW TRANSPLANTATION, 2018, 53 : 557 - 558
  • [2] Candida kefyr:: a new emerging pathogen?
    Agudo, S.
    Navarro, J.
    Cuevas, C. De las
    Moreno, M.
    Buendia, B.
    Domingo, D.
    Alarcon, T.
    Brea, M. Lopez
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S355 - S356
  • [3] Is Candida kefyr an emerging pathogen in patients with oncohematological diseases?
    Sendid, Boualem
    Lacroix, Claire
    Bougnoux, Marie-Elisabeth
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (05) : 666 - 667
  • [4] Candida kefyr, an uncommon but emerging fungal pathogen:: Report of two cases
    Corpus, K
    Hegeman-Dingle, R
    Bajjoka, I
    PHARMACOTHERAPY, 2004, 24 (08): : 1084 - 1088
  • [5] Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients
    Reuter, CWM
    Morgan, MA
    Bange, FC
    Gunzer, F
    Eder, M
    Hertenstein, B
    Ganser, A
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) : 1365 - 1366
  • [6] Bloodstream infection with Candida kefyr/Kluyveromyces marxianus: case report and draft genome
    Seth-Smith, H. M. B.
    Buchler, A. C.
    Hinic, V.
    Medinger, M.
    Widmer, A. F.
    Egli, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (04) : 522 - 524
  • [7] CANDIDA KEFYR AS AN EMERGING PATHOGEN CAUSING BLOODSTREAM INFECTION IN PEDIATRIC NEUTROPENIC LEUKEMIA PATIENT. IS IT RELATED WITH DIETARY HABITS?
    Tugcu, D.
    Karagenc, A. Ozkan
    Acar, M. Kara
    Karaman, S.
    Aydogdu, S.
    Somer, A.
    Erturan, Z.
    Karakas, Z.
    LEUKEMIA RESEARCH, 2017, 61 : S47 - S48
  • [8] CANDIDA KEFYR PNEUMONIA
    Kocabay, Gonenc
    Aydin, Sinan
    Tiryak, Betul
    Vatansever, Sezai
    Erk, Osman
    Akkaya, Vakur
    Guler, Kerim
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2005, 68 (01): : 26 - 28
  • [9] First case of Kluyveromyces marxianus (Candida kefyr) late onset keratitis after lamellar endothelial corneal graft
    Aldejohann, Alexander M.
    Theuersbacher, Johanna
    Haug, Lukas
    Lamm, Olga S.
    Walther, Grit
    Kurzai, Oliver
    Hillenkamp, Jost
    Kampik, Daniel
    MEDICAL MYCOLOGY CASE REPORTS, 2021, 32 : 21 - 24
  • [10] Candida auris: An emerging fungal pathogen
    Chowdhary, A.
    MYCOSES, 2017, 60 : 48 - 48